Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Among Americans who have never taken GLP-1s but are considering beginning treatment in the next 12 months, 25.1% cite the pill option as the primary factor influencing their desire to begin treatment, and among the 9.3% of Americans who have discontinued GLP-1 treatments, 44.1% say they are considering resuming treatments because of pill options
doi: 10.1038/s41392-023-01496-3, 6
Scientists have found that GLP-1 peptides, once mainly linked to blood sugar regulation, also influence appetite, inflammation, and aspects of brain function
Two-thirds of the sites did so with zero interaction with a clinician, putting consumers at risk of health complications
